Shanghai Pharmaceuticals Holding Co(DE:S1R)
€1.22-0.02 (-1.61%)
DE:S1R
Shanghai Pharmaceuticals Holding Co financials statements
€1.22
At close:-0.02 (-1.61%)
Shanghai Pharmaceuticals Holding Co (S1R) Income Statement
1 Followers
Shanghai Pharmaceuticals Holding Co Income Statement
Last quarter (Q3 2026), Shanghai Pharmaceuticals Holding Co's total revenue was ¥75.48B, an increase of 2.76% from the same quarter last year. In Q3, Shanghai Pharmaceuticals Holding Co's net income was ¥1.08B. See Shanghai Pharmaceuticals Holding Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 283.58B | ¥ 275.25B | ¥ 260.30B | ¥ 231.98B | ¥ 215.82B | |
| ¥ 30.42B | ¥ 30.63B | ¥ 30.93B | ¥ 30.49B | ¥ 28.54B | |
| ¥ 20.47B | ¥ 22.49B | ¥ 23.26B | ¥ 21.71B | ¥ 20.62B | |
| Depreciation and Amortization | ¥ 2.86B | ¥ 2.42B | ¥ 2.19B | ¥ 2.22B | ¥ 2.14B |
| ¥ 14.37B | ¥ 12.06B | ¥ 10.90B | ¥ 12.44B | ¥ 10.55B | |
| ¥ 9.94B | ¥ 8.14B | ¥ 7.67B | ¥ 9.01B | ¥ 8.21B | |
| ¥ -122.28M | ¥ -120.71M | ¥ -612.94M | ¥ -206.30M | ¥ -61.67M | |
| ¥ 9.82B | ¥ 8.02B | ¥ 7.05B | ¥ 8.81B | ¥ 8.14B | |
| ¥ 5.72B | ¥ 4.55B | ¥ 3.77B | ¥ 5.62B | ¥ 5.09B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.54 | ¥ 1.23 | ¥ 1.02 | ¥ 1.61 | ¥ 1.79 |
| Diluted EPS | ¥ 1.54 | ¥ 1.23 | ¥ 1.02 | ¥ 1.61 | ¥ 1.79 |
| Weighted Average Shares Outstanding | 3.71B | 3.70B | 3.70B | 3.48B | 2.84B |
| Weighted Average Shares Outstanding (Diluted) | 3.71B | 3.70B | 3.70B | 3.49B | 2.85B |
Currency in CNY

